Article Information
- Received March 4, 2004
- Revision received July 29, 2004
- Accepted July 29, 2004
- First published September 8, 2004.
- Version of record published September 8, 2004.
Author Information
- Kenneth J. Rhodes1,
- Karen I. Carroll1,
- M. Amy Sung1,
- Lisa C. Doliveira1,
- Michael M. Monaghan1,
- Sharon L. Burke1,
- Brian W. Strassle1,
- Lynn Buchwalder2,
- Milena Menegola4,
- Jie Cao3,
- W. Frank An3, and
- James S. Trimmer2,4
- 1Neuroscience, Wyeth Discovery Research, Princeton, New Jersey 08543, 2Department of Biochemistry and Cell Biology, State University of New York, Stony Brook, New York 11794, 3Millennium Pharmaceuticals, Cambridge, Massachusetts 02139, and 4Department of Pharmacology, School of Medicine, University of California, Davis, California 95616
Author contributions
Disclosures
- Received March 4, 2004.
- Revision received July 29, 2004.
- Accepted July 29, 2004.
This work was supported by Wyeth Research and by National Institutes of Health Grant NS42225 (J.S.T.). We thank Dr. Pranab Chanda and Wade Edris for preparation and purification of KChIP fusion proteins, Dr. Gail Mandel for the use of the confocal microscope and luminometer, and Drs. Mark Bowlby, John Moyer, James Barrett, Peter DiStefano, and Kevin Willis for support and encouragement during the course of this work.
Correspondence should be addressed to Dr. James S. Trimmer, Department of Pharmacology, 1311 Tupper Hall, School of Medicine, University of California, One Shields Avenue, Davis, CA 95616-8635. E-mail: jtrimmer{at}ucdavis.edu.
K. J. Rhodes's present address: Neurological Disorders, Johnson and Johnson Pharmaceutical Research and Development, Raritan, NJ 08869.
Copyright © 2004 Society for Neuroscience 0270-6474/04/247903-13$15.00/0
Online Impact